All News

RheumNow Podcast square

RheumNow Podcast – Falling or Falling in Love?

d Jack Cush, MD

Dr. Jack Cush reviews the best journal articles from the past week on RheumNow.com.

Read Article
microbio2.jpg

Unique Oral Microbiome in Early and Pre-Clinical RA

d Jack Cush, MD

An oral microbiome study of rheumatoid arthritis patients suggests that periodontal condition in patients with early rheumatoid arthritis and individuals at risk of RA.

Read Article
Step, down, arrow, blocks

ARTIC REWIND - Don't Half DMARD Therapy

d Jack Cush, MD

The ARTIC-REWIND study examined rheumatoid arthritis (RA) patients in remission on conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) to see if they could "step-down" their csDMARDs theray; but  the study showed that 25% those who went on half-dose experienced disease fl

Read Article
Level, monitor, calculate, glucose, diabetes

Drug Monitoring Ineffective with Infliximab Treatment

d Jack Cush, MD

The predictive value of therapeutic drug monitoring (TDM) while on biologics is debateable; gastroenterology routinely relies on TDM, while rheumatologists do not.

Read Article
kid, lupus, pediatric

Childhood Lupus May Hamper Adult Careers

d Jack Cush, MD

Long-term outcomes of kids with childhood-onset systemic lupus erythematosus (cSLE) are uncommon, but this cSLE cohort analysis suggests that SLE significantly impacts their future education, vocation, and employment as they reach adulthood.

Read Article
Today begins National Nurses week! God Bless Rheumatology Nurses https://t.co/JC9ExqnXEb #ArthritisAwarenessMonth https://t.co/bhuocIlHWT

Links:

Dr. John Cush RheumNow ( View Tweet)
News Feature: Childhood Lupus May Hamper Adult Careers Long-term outcomes of kids with cSLE are uncommon, but this cSLE cohort analysis suggests that SLE significantly impacts their future education, vocation, and employment as they reach adulthood. https://t.co/RQc4JD3BIt https://t.co/l0ZQWHNFng

Links:

Dr. John Cush RheumNow ( View Tweet)
#LupusAwarenessMonth Dr. Kathryn Dao - Pregnancy Outcomes in Lupus, SpA From ACR 2020 https://t.co/TvlqwZqgOv https://t.co/UBeVghYh0g

Links:

Dr. John Cush RheumNow ( View Tweet)
Join us each Tuesday for Tuesday Night Rheumatology. We'll have new speakers each week and a Q&A session available following the discussion. https://t.co/ugGaPvBsLD https://t.co/CCua5Uvl7f

Links:

Dr. John Cush RheumNow ( View Tweet)
Study of healthcare resource utilization and costs psoriasis, psoriatic arthritis (PsA) vs controls; PsA has the highest annual all-cause healthcare costs per patient - Controls =$7,470, Psoriasis= $11,062, and PsA = $29,742 https://t.co/06irRupcLJ

Links:

Dr. John Cush RheumNow ( View Tweet)

Systematic review 6 studies of ischemic stroke and Idiopathic inflammatory myopathies (IIM) shows among 5,114 IIM cases there was an increased risk of ischemic stroke (RR = 2.41, 95% CI: 1.31, 4.45), 49% higher in dermatomyositis and Asian IIM. https://t.co/gYdMgmU5Uh

Links:

Dr. John Cush RheumNow ( View Tweet)

News Feature: Autoimmune Thyroid Disease in Women JAMA has posted an insights article reviewing autoimmune thyroid disease in women. Thyroid autoimmunity has a higher prevalence in women and with increasing age. https://t.co/P55lMMagyO https://t.co/yMWJClvVJO

Links:

Dr. John Cush RheumNow ( View Tweet)
Did you miss last night's Tuesday Night Rheumatology? Watch the playback now. https://t.co/8fjseHpSQV https://t.co/x4NSftQuRQ

Links:

Dr. John Cush RheumNow ( View Tweet)
News Feature: Results Disappoint for Fecal Transplant in Arthritis Fecal microbiota transplantation (FMT) showed disappointing results among patients with active psoriatic arthritis, a small randomized trial found. https://t.co/US96DAa9XR https://t.co/IzWZJJe1RX

Links:

Dr. John Cush RheumNow ( View Tweet)
May is Lupus month! We've compiled some great lupus resources to share throughout the month. #LupusAwarenessMonth Dr. Janet Pope - Modifying risk of Lupus and RA From ACR 2020 https://t.co/f8a6vHB31e https://t.co/8jteX3F5qg

Links:

Dr. John Cush RheumNow ( View Tweet)
Belimumab now approved in the EU for lupus nephritis. The EMA has approved intravenous and subcutaneous Benlysta (belimumab) in combination with background immunosuppressive therapies for adults with active lupus nephritis https://t.co/Twbe1ClT5w

Links:

Dr. John Cush RheumNow ( View Tweet)

TNF inhibitor induced (paradoxical) psoriasis in JIA patients was 3 fold higher when TNFi was used - data from 8,222 children in the CARRA registry (54% used TNFi) - rate 8.5 cases/1000PY. https://t.co/HKpAEbtNqr https://t.co/txvmGfpdWf

Links:

Dr. John Cush RheumNow ( View Tweet)

27 cases of #immune-mediated diseases post #COVIDVaccination ▶️21 had autoimmune/rheumatic background ▶️17 flares, 10 new onset ▶️Average 4 days post #covidvaccine ▶️>80% had resolution, mostly with corticosteroid 👉🏽https://t.co/zHlFziswU7 via @Vaccines_MDPI @MDPIOpenAccess https://t.co/5ifoBmb9Ux

Links:

Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
#VACOLUP study about #COVID19 #vaccine in #lupus = reassuring data for #SLE patients : side-effects are minor/moderate in 80% and the rate of lupus #flare is stable at 3-4%. Thanks to the 571 patients who have already participated 🙏. Link: https://t.co/I0D52fv4BC https://t.co/us0kQlvkVS

Links:

Laurent ARNAUD Lupusreference ( View Tweet)
Zoomatology – Present in Absentia Unknowingly, you have become a zoomatologist – an old dog who has mastered the new trick. Despite the shutdowns and lockdowns, you can be everywhere, do everything, and learn by being present in absentia. https://t.co/8iAV5gvkkt https://t.co/zEYvnVuari

Links:

Dr. John Cush RheumNow ( View Tweet)
×